Skip to content
10-Q

Quarterly Report

ACCELERON PHARMA INC.

0001280600-21-000038

← back to feed
Filed
May 6, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Apr 30, 2021 60.7M sh
Capex Q1 2021 · Mar 31, 2021 $920K
Capex Q1 2021 · Mar 31, 2020 $426K
Operating Cash Flow Q1 2021 · Mar 31, 2021 −$67.92M
Operating Cash Flow Q1 2021 · Mar 31, 2020 −$46.55M
Short Term Investments Q1 2021 · Mar 31, 2021 $231.74M
Short Term Investments Q1 2021 · Dec 31, 2020 $178.95M
Cash And Equivalents Q1 2021 · Mar 31, 2021 $455.51M
Cash And Equivalents Q1 2021 · Dec 31, 2020 $670.95M
Cash And Equivalents Q1 2021 · Mar 31, 2020 $277.49M
Stockholders Equity Q1 2021 · Mar 31, 2021 $810.83M
Stockholders Equity Q1 2021 · Dec 31, 2020 $855.11M
Stockholders Equity Q1 2021 · Mar 31, 2020 $413.82M
Stockholders Equity Q1 2021 · Dec 31, 2019 $449.48M
Current Liabilities Q1 2021 · Mar 31, 2021 $49.82M
Current Liabilities Q1 2021 · Dec 31, 2020 $60.16M
Total Liabilities Q1 2021 · Mar 31, 2021 $64.96M
Total Liabilities Q1 2021 · Dec 31, 2020 $77.23M
Current Assets Q1 2021 · Mar 31, 2021 $737.61M
Current Assets Q1 2021 · Dec 31, 2020 $893.27M
Total Assets Q1 2021 · Mar 31, 2021 $875.79M
Total Assets Q1 2021 · Dec 31, 2020 $932.34M
Sga Expense Q1 2021 · Mar 31, 2021 $31.06M
Sga Expense Q1 2021 · Mar 31, 2020 $18.25M
Rd Expense Q1 2021 · Mar 31, 2021 $57.3M
Rd Expense Q1 2021 · Mar 31, 2020 $37.66M
Net Income Q1 2021 · Mar 31, 2021 −$63.47M
Net Income Q1 2021 · Mar 31, 2020 −$50.94M
Operating Income Q1 2021 · Mar 31, 2021 −$63.6M
Operating Income Q1 2021 · Mar 31, 2020 −$51.57M
Revenue Q1 2021 · Mar 31, 2021 $24.76M
Revenue Q1 2021 · Mar 31, 2020 $4.34M